2-[(6-Acetamidopyridin-3-yl)sulfanyl]-N-(3-methoxypropyl)benzamide

Catalog No. :
ACMVGF278
CAS No. :
343373-11-5
Molecular Formula :
C18H21N3O3S
Molecular Weight :
359.45

IUPAC Name:2-((6-acetamidopyridin-3-yl)thio)-N-(3-methoxypropyl)benzamide

2-[(6-Acetamidopyridin-3-yl)sulfanyl]-N-(3-methoxypropyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[(6-Acetamidopyridin-3-yl)sulfanyl]-N-(3-methoxypropyl)benzamide
IUPAC Name2-((6-acetamidopyridin-3-yl)thio)-N-(3-methoxypropyl)benzamide
MDL No.MFCD01315219
Molecular FormulaC18H21N3O3S
Molecular Weight359.45
SMILESO=C(NCCCOC)C1=CC=CC=C1SC2=CC=C(NC(C)=O)N=C2
InChI KeySEDXMCOGODDGDU-UHFFFAOYSA-N
Synonym2-([6-(ACETYLAMINO)-3-PYRIDINYL]SULFANYL)-N-(3-METHOXYPROPYL)BENZENECARBOXAMIDE;2-[(6-acetamidopyridin-3-yl)sulfanyl]-N-(3-methoxypropyl)benzamide;Benzamide, 2-[[6-(acetylamino)-3-pyridinyl]thio]-N-(3-methoxypropyl)-
CAS No.343373-11-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMVGF278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBWAG179 route compound structure diagram
    ACBWAG17918600-41-4 In Stock
  4. Then
  5. ACMVGF278 route product structure diagram
    ACMVGF278343373-11-5
Inquiry

2. ACMVGF278 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMVGF278 route product structure diagram
    ACMVGF278343373-11-5
Inquiry

Comments (0)